NCT05984069 Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported
| NCT ID | NCT05984069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Post Intensive Care Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2022-07-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After a prolonged stay in Intensive Care Unit (ICU), fatigue is the most common symptom reported by patients in the Post Intensive Care Syndrome (PICS). Other complications have been described, including ICU-acquired weakness, leading to increased morbidity and mortality after discharge. Actually, risk factors associated with post-ICU fatigue self-reported are not really known.
Eligibility Criteria
Inclusion Criteria: * Patients with a length of stay in intensive care \> or equal to 7 days, or mechanical ventilation \> or equal to 5 days Exclusion Criteria: * Scheduled surgery with admission in ICU * Pregnancy * Guardianship
Contact & Investigator
Jérôme MOREL, MD PhD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT05984069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Intensive Care Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05984069 currently recruiting?
Yes, NCT05984069 is actively recruiting participants. Contact the research team at jerome.morel@chu-st-etienne.fr for enrollment information.
Where is the NCT05984069 trial being conducted?
This trial is being conducted at Saint-Etienne, France, Saint-Etienne, France.
Who is sponsoring the NCT05984069 clinical trial?
NCT05984069 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Jérôme MOREL, MD PhD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 150 participants.